Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Flex Pharma logo — company profile

Flex Pharma

Founded 2014 United States Boston, United States 5 employees Series Unknown Total: $40.00M Biotechnology, Health Care +3

General Information

Company Name Flex Pharma
Founded Year 2014
Location United States Boston, United States +1
Employees 5
Industries Biotechnology, Health Care, Life Sciences +2
Funding Stage Series Unknown
Social

Get notified when Flex Pharma moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Flex Pharma

Flex Pharma is a biopharmaceutical company founded in 2014 in the United States. The company focuses on developing innovative treatments for neuromuscular disorders, specifically targeting muscle cramps. It has shown promising human efficacy in addressing muscle cramping through its novel approach. Unlike traditional remedies such as sports drinks and stretching, which are often ineffective, Flex Pharma's research indicates that muscle cramps and spasms are caused by neural mechanisms, specifically the excessive firing of motor neurons in the spinal cord. The company's products aim to halt this repetitive firing, offering relief from muscle cramps and spasms within minutes, with effects lasting for hours. The company's founders include esteemed professors from Harvard Medical School and Rockefeller University, and it has garnered significant attention from investors. Flex Pharma has received a $40.00M Venture Round investment from a consortium of renowned investors including Bessemer Venture Partners, Correlation Ventures, Spark Capital, Bindley Capital, City Hill Ventures, EcoR1 Capital, QVT Financial, CD-Venture, Jennison Associates, and Alexandria Real Estate Equities, demonstrating strong support and interest in the company's vision and potential. Overall, Flex Pharma's pioneering approach to addressing neuromuscular disorders, backed by a notable founding team and substantial investment, positions the company as a compelling player in the biotechnology and pharmaceutical industries.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 10
Investor Investor Investor Investor Investor Investor Investor
•••• •••• 		08 Sep 2014

Flex Pharma Alternatives & Competitors

Flex Pharma vs
NMD Pharma A/S
NMD Pharma A/S Denmark

A clinical-stage biotech company focused on developing life-changing therapies for neuromuscular dis...

Series B
61 employees
Health and Wellness, Pharmaceutical
Flex Pharma vs
Anagenesis Biotechnologies
Anagenesis Biotechnologies France

Development of new regenerative medicines

2-10 employees
Biotechnology
Flex Pharma vs
Scholar Rock
Scholar Rock United States

Scholar Rock is a biopharmaceutical company that discovers, develops and delivers life-changing ther...

Post Ipo Equity
199 employees
Biopharma, Biotechnology

FAQ About Flex Pharma

Our Company: Novel Treatments for Neuromuscular Disorders. Flex Pharma is a biopharmaceutical company dedicated to creating innovative, novel treatments for neuromuscular disorders, and has demonstrated human efficacy related to muscle cramping. Novel Treatments for Neuromuscular Disorders,...
Flex Pharma was founded in 2014.
Flex Pharma is headquartered in Boston, United States.
Flex Pharma operates in the following industries: Biotechnology, Health Care, Life Sciences, Medical Devices, Pharmaceutical.
Flex Pharma has approximately 5 employees.
Flex Pharma has completed 1 funding round, raising a total of $40.00M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Flex Pharma include NMD Pharma A/S, Anagenesis Biotechnologies, Scholar Rock, Neuronascent, Inc, GB Sciences, Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Flex Pharma and NMD Pharma A/S are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Flex Pharma and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy